SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
NEW PrEP AGENTS AND FORMULATIONS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
WEEKLY ORAL TENOFOVIR ALAFENAMIDE PROTECTS MACAQUES FROM VAGINAL SHIV INFECTION (ABSTRACT
714)
Ivana Massud
Centers for Disease Control and Prevention, Atlanta, GA, USA
PHARMACOKINETICS OF TAF/EVG RECTAL INSERTS IN MACAQUES AND IMPACT OF RECTAL WASH (ABSTRACT
715)
Natalia Makarova
Center for Disease Control and Prevention, Atlanta, GA, USA
ACCEPTABILITY AND CHOICE FOR 3 PLACEBO PRODUCTS USED WITH RECEPTIVE ANAL SEX (ABSTRACT
716)
José A Bauermeister
University of Pennsylvania, Philadelphia, PA, USA
LONG-ACTING HIV CAPSID INHIBITOR EFFECTIVE AS PREP IN A SHIV RHESUS MACAQUE MODEL (ABSTRACT
717)
Elena Bekerman
Gilead Sciences, Foster City, CA, USA
INFUSION REACTIONS IN THE PHASE 2B ANTIBODY MEDIATED PREVENTION (AMP) STUDIES (ABSTRACT
718)
Simbarashe Takuva
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, Seattle, WA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
